Skip to content

Clinical trials

Phase 1/2 Leukemia, Lymphocytic, Chronic, B-Cell trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Lymphocytic, Chronic, B-Cell Phase: Phase 1/2 Country / region: United Kingdom Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20072
20121
20141
20151
20162
20181
20191
20212
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Recruiting4
Active, not recruiting2
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
BeOne Medicines2
AbbVie1
Acerta Pharma BV1
AstraZeneca1
Celgene1
Eisai Limited1
Genentech, Inc.1
Genmab1
Kartos Therapeutics, Inc.1
Loxo Oncology, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Lymphocytic, Chronic, B-Cell14
Lymphoma, Mantle-Cell6
Lymphoma, Non-Hodgkin5
Lymphoma, Large B-Cell, Diffuse4
Lymphoma, B-Cell3
Lymphoma, B-Cell, Marginal Zone3
Lymphoma, Follicular3
Lymphoma2
Waldenstrom Macroglobulinemia2
Dendritic Cell Sarcoma, Interdigitating1

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.